Gilead Sciences Inc (GILD) Financials
Key financial figures for Gilead Sciences Inc (Q2 2026).
- Revenue
- $7.8B
- Net Income
- -$10.5B
- EPS
- $-8.45
- Total Assets
- $49.4B
- Operating Cash Flow
- $3.6B
Full income statement, balance sheet, and cash flow for Gilead Sciences Inc on SentiSense.